Work M E, John E M, Andrulis I L, Knight J A, Liao Y, Mulligan A M, Southey M C, Giles G G, Dite G S, Apicella C, Hibshoosh H, Hopper J L, Terry M B
Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032, USA.
1] Cancer Prevention Institute of California, Fremont, CA 94538, USA [2] Division of Epidemiology, Department of Health Research and Policy, and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305-5101, USA.
Br J Cancer. 2014 Mar 4;110(5):1367-77. doi: 10.1038/bjc.2013.807. Epub 2014 Feb 18.
Oestrogen receptor (ER)- and progesterone receptor (PR)-negative (ER-PR-) breast cancer is associated with poorer prognosis compared with other breast cancer subtypes. High parity has been associated with an increased risk of ER-PR- cancer, but emerging evidence suggests that breastfeeding may reduce this risk. Whether this potential breastfeeding benefit extends to women at high risk of breast cancer remains critical to understand for prevention.
Using population-based ascertained cases (n=4011) and controls (2997) from the Breast Cancer Family Registry, we examined reproductive risk factors in relation to ER and PR status.
High parity (≥3 live births) without breastfeeding was positively associated only with ER-PR- tumours (odds ratio (OR)=1.57, 95% confidence interval (CI), 1.10-2.24); there was no association with parity in women who breastfed (OR=0.93, 95% CI 0.71-1.22). Across all race/ethnicities, associations for ER-PR- cancer were higher among women who did not breastfeed than among women who did. Oral contraceptive (OC) use before 1975 was associated with an increased risk of ER-PR- cancer only (OR=1.32, 95% CI 1.04-1.67). For women who began OC use in 1975 or later there was no increased risk.
Our findings support that there are modifiable factors for ER-PR- breast cancer and that breastfeeding in particular may mitigate the increased risk of ER-PR- cancers seen from multiparity.
与其他乳腺癌亚型相比,雌激素受体(ER)和孕激素受体(PR)均为阴性(ER-PR-)的乳腺癌预后较差。高生育次数与ER-PR-癌症风险增加有关,但新出现的证据表明,母乳喂养可能会降低这种风险。对于预防而言,这种潜在的母乳喂养益处是否也适用于乳腺癌高危女性,仍有待深入了解。
我们利用乳腺癌家族登记处基于人群确定的病例(n = 4011)和对照(2997),研究了与ER和PR状态相关的生殖风险因素。
未进行母乳喂养的高生育次数(≥3次活产)仅与ER-PR-肿瘤呈正相关(比值比(OR)= 1.57,95%置信区间(CI),1.10 - 2.24);母乳喂养的女性生育次数与之无关联(OR = 0.93,95% CI 0.71 - 1.22)。在所有种族/族裔中,未进行母乳喂养的女性患ER-PR-癌症的相关性高于进行母乳喂养的女性。1975年前使用口服避孕药(OC)仅与ER-PR-癌症风险增加有关(OR = 1.32,95% CI 1.04 - 1.67)。1975年或之后开始使用OC的女性,风险未增加。
我们的研究结果支持ER-PR-乳腺癌存在可改变的因素,特别是母乳喂养可能会减轻多产导致的ER-PR-癌症风险增加。